Chemours Company (The) Common Stock (NY:CC)

Everything that could have gone wrong for Chemours stock today did go wrong.

Why Chemours Stock Crashed 37% This Morning ↗

February 29, 2024

Via The Motley Fool

Earnings Outlook For Chemours ↗

February 13, 2024

Via Benzinga

Nasdaq Gains 100 Points Following PCE Data ↗

February 29, 2024

U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 100 points on Thursday. Following the market opening Thursday, the Dow traded down 0.07% to 38,923.11 while the...

Via Benzinga

Topics Stocks

Chemours Stock Tumbles As Company Reveals Management Shakeup And Financial Struggles ↗

February 29, 2024

Chemours Company reports prelim results, management changes, and delay in 10-K form. Net sales down, net loss expected.

Via Benzinga

Why Is Ironwood Pharmaceuticals (IRWD) Stock Down 27% Today? ↗

February 29, 2024

Ironwood Pharmaceuticals stock is falling on Thursday with investors in IRWD unimpressed by its latest Phase III clinical trial results.

Via InvestorPlace

Why Is Chemours (CC) Stock Down 36% Today? ↗

February 29, 2024

Chemours stock is falling on Thursday as CC investors react to management changes going into effect due to an internal review.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

February 29, 2024

It's time to dive into the biggest pre-market stock movers for Thursday as we check out all of the news affecting shares this morning!

Via InvestorPlace

Shoals Technologies Posts Weak Q4 Results, Joins Butterfly Network, Schrödinger And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

February 29, 2024

U.S. stock futures were lower this morning, with the Dow futures trading lower by over 100 points on Thursday.

Via Benzinga

Topics Stocks

CORRECTING and REPLACING Chemours Announces Management Actions and Delay of Form 10-K; Provides Preliminary Unaudited 2023 Year-End Results

February 29, 2024

CC INVESTOR NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation - CC

February 27, 2024

WHY: NEW YORK, NY - (NewMediaWire) - February 27, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The...

Via NewMediaWire

CC INVESTOR NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation - CC

February 27, 2024

WHY: NEW YORK, NY - (NewMediaWire) - February 27, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The...

Via TheNewswire.com

The Chemours Company (CC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

February 26, 2024

From Bronstein, Gewirtz & Grossman, LLC

ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation – CC

February 24, 2024

From The Rosen Law Firm PA

Kirby McInerney LLP is Investigating Potential Shareholder Claims Against The Chemours Company (CC)

February 21, 2024

From Kirby McInerney LLP

Bragar Eagel & Squire, P.C. Is Investigating Waldencast, and Chemours and Encourages Investors to Contact the Firm

February 20, 2024

From Bragar Eagel & Squire

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation - CC

February 20, 2024

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation - CC

February 20, 2024

WHY: NEW YORK, NY - (NewMediaWire) - February 20, 2024 - Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of The...

Via TheNewswire.com

GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation – CC

February 19, 2024

From The Rosen Law Firm PA

Chemours Announces Changes to its Board of Directors

February 16, 2024

CHEMOURS ALERT: Bragar Eagel & Squire, P.C. is Investigating The Chemours Company on Behalf of Chemours Stockholders and Encourages Investors to Contact the Firm

February 15, 2024

From Bragar Eagel & Squire

CC LOSS ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation – CC

February 15, 2024

From The Rosen Law Firm, P.A.

Lost Money in The Chemours Company? Gibbs Law Group Investigates Potential Securities Law Violations

February 14, 2024

From Gibbs Law Group

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of The Chemours Company (CC) on Behalf of Investors

February 14, 2024

From Glancy Prongay & Murray LLP

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of The Chemours Company (CC) on Behalf of Investors

February 14, 2024

From Law Offices of Howard G. Smith

The Law Offices of Frank R. Cruz Announces Investigation of The Chemours Company (CC) on Behalf of Investors

February 14, 2024

From The Law Offices of Frank R. Cruz

Why Sony Shares Are Trading Lower By Around 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 14, 2024

Shares of Sony Group Corporation (NYSE: SONY) fell during Wednesday’s session after the company reported third-quarter financial results and revised guidance above estimates and shared plans to list...

Via Benzinga

Chemours Announces First Quarter Dividend

February 13, 2024

Chemours Reschedules Earnings Release and Conference Call

February 13, 2024